Dark Forest Capital Management LP Aerie Pharmaceuticals Inc Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$5.64 - $9.8 $30,399 - $52,822
-5,390 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$7.02 - $13.33 $28,950 - $54,972
4,124 Added 325.75%
5,390 $38,000
Q3 2021

Nov 12, 2021
BUY
$11.32 - $16.63 $14,331 - $21,053
1,266 New
1,266 $14,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email